Zonghao You

553 total citations
20 papers, 397 citations indexed

About

Zonghao You is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Zonghao You has authored 20 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Cancer Research and 4 papers in Immunology. Recurrent topics in Zonghao You's work include Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (5 papers) and RNA modifications and cancer (4 papers). Zonghao You is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (5 papers) and RNA modifications and cancer (4 papers). Zonghao You collaborates with scholars based in China, Bangladesh and United States. Zonghao You's co-authors include Ming Chen, Bin Xu, Han Guan, Zhixin Ling, Chunhui Liu, Shuqiu Chen, Can Wang, Shuqiu Chen, Guangyuan Zhang and Yali Wang and has published in prestigious journals such as Oncogene, Scientific Reports and Science Advances.

In The Last Decade

Zonghao You

18 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zonghao You China 9 309 220 58 50 43 20 397
Zhi Xu China 12 307 1.0× 236 1.1× 72 1.2× 60 1.2× 56 1.3× 20 452
Yanyan Liu China 10 302 1.0× 259 1.2× 44 0.8× 25 0.5× 34 0.8× 23 392
Zongli Ding China 11 321 1.0× 214 1.0× 43 0.7× 22 0.4× 59 1.4× 18 386
Jianjun Xu China 13 284 0.9× 159 0.7× 40 0.7× 39 0.8× 55 1.3× 17 345
Jiaxiang Wang China 10 176 0.6× 122 0.6× 50 0.9× 28 0.6× 55 1.3× 24 295
Mehrdokht Sadrkhanloo Iran 8 245 0.8× 180 0.8× 57 1.0× 46 0.9× 88 2.0× 10 381
Jialin Feng China 12 310 1.0× 230 1.0× 42 0.7× 32 0.6× 55 1.3× 22 430
Elahe Sadat Hejazi Iran 6 217 0.7× 150 0.7× 46 0.8× 31 0.6× 68 1.6× 9 316

Countries citing papers authored by Zonghao You

Since Specialization
Citations

This map shows the geographic impact of Zonghao You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zonghao You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zonghao You more than expected).

Fields of papers citing papers by Zonghao You

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zonghao You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zonghao You. The network helps show where Zonghao You may publish in the future.

Co-authorship network of co-authors of Zonghao You

This figure shows the co-authorship network connecting the top 25 collaborators of Zonghao You. A scholar is included among the top collaborators of Zonghao You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zonghao You. Zonghao You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jiawei, Feng Ding, Xiaoying Wei, et al.. (2025). AI-based prediction of androgen receptor expression and its prognostic significance in prostate cancer. Scientific Reports. 15(1). 3985–3985.
2.
3.
You, Zonghao, et al.. (2024). Tissue damage from chronic liver injury inhibits peripheral NK cell abundance and proinflammatory function. Journal of Leukocyte Biology. 115(6). 1042–1052. 2 indexed citations
4.
You, Zonghao, et al.. (2024). The influence of skin microbial ecology on γδ T-cell immune pathways in allergic dermatitis models in mice. Journal of Leukocyte Biology. 117(5). 2 indexed citations
5.
Chen, Saisai, Kai Lǚ, Yue Hou, et al.. (2023). YY1 complex in M2 macrophage promotes prostate cancer progression by upregulating IL-6. Journal for ImmunoTherapy of Cancer. 11(4). e006020–e006020. 65 indexed citations
6.
Piunti, Andrea, Khyati Meghani, Yanni Yu, et al.. (2022). Immune activation is essential for the antitumor activity of EZH2 inhibition in urothelial carcinoma. Science Advances. 8(40). eabo8043–eabo8043. 31 indexed citations
7.
Liu, Chunhui, Weipu Mao, Zonghao You, et al.. (2022). Associations between exposure to different heavy metals and self-reported erectile dysfunction: a population-based study using data from the 2001-2004 National Health and Nutrition Examination Survey. Environmental Science and Pollution Research. 29(49). 73946–73956. 4 indexed citations
8.
Li, Wenchao, Qiang Hu, Ninghan Feng, et al.. (2022). Transgenic construction and functional miRNA analysis identify the role of miR-7 in prostate cancer suppression. Oncogene. 41(41). 4645–4657. 8 indexed citations
9.
You, Zonghao, et al.. (2022). The role of γδ T17 cells in cardiovascular disease. Journal of Leukocyte Biology. 112(6). 1649–1661. 3 indexed citations
10.
Xu, Bin, Minhao Zhang, Chunhui Liu, et al.. (2020). Association of Long Non-Coding RNA MEG3 Polymorphisms and Risk of Prostate Cancer in Chinese Han Population.. PubMed. 18(2). 176–180. 8 indexed citations
11.
Xu, Bin, Yali Wang, Shuqiu Chen, et al.. (2020). miR‐143 inhibits renal cell carcinoma cells metastatic potential by suppressing ABL2. The Kaohsiung Journal of Medical Sciences. 36(8). 592–598. 7 indexed citations
12.
You, Zonghao, Chunhui Liu, Can Wang, et al.. (2019). LncRNA CCAT1 Promotes Prostate Cancer Cell Proliferation by Interacting with DDX5 and MIR-28-5P. Molecular Cancer Therapeutics. 18(12). 2469–2479. 74 indexed citations
13.
Liu, Chunhui, Lusi Chen, Zonghao You, et al.. (2019). Association between lncRNA H19 polymorphisms and cancer susceptibility based on a meta-analysis from 25 studies. Gene. 729. 144317–144317. 16 indexed citations
14.
Zhang, Minhao, Yali Wang, Can Wang, et al.. (2019). Association of Hsa-miR-23a rs3745453 variation with prostate cancer risk among Chinese Han population. Medicine. 98(52). e18523–e18523. 2 indexed citations
15.
Guan, Han, Zonghao You, Can Wang, et al.. (2019). MicroRNA‐200a suppresses prostate cancer progression through BRD4/AR signaling pathway. Cancer Medicine. 8(4). 1474–1485. 37 indexed citations
16.
Ling, Zhixin, Zonghao You, Ling Hu, et al.. (2018). Effects of four single nucleotide polymorphisms of <em>EZH2</em> on cancer risk: a systematic review and meta-analysis. OncoTargets and Therapy. Volume 11. 851–865. 6 indexed citations
17.
Ling, Zhixin, Han Guan, Zonghao You, et al.. (2018). Aloperine executes antitumor effects through the induction of apoptosis and cell cycle arrest in prostate cancer in vitro and in vivo. OncoTargets and Therapy. Volume 11. 2735–2743. 41 indexed citations
18.
Ling, Zhixin, Xiaoyan Wang, Tao Tao, et al.. (2017). Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer. Journal of Experimental & Clinical Cancer Research. 36(1). 159–159. 46 indexed citations
19.
Guan, Han, Chunhui Liu, Fang Fang, et al.. (2017). MicroRNA-744 promotes prostate cancer progression through aberrantly activating Wnt/β-catenin signaling. Oncotarget. 8(9). 14693–14707. 42 indexed citations
20.
Zheng, Ruzhen, Zonghao You, Shengyou Lin, et al.. (2015). Efficacy of percutaneous radiofrequency ablation for the treatment of hepatocellular carcinoma. Genetics and Molecular Research. 14(4). 17982–17994. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhi Xu Breakdown of academic impact, for papers by Yanyan Liu Breakdown of academic impact, for papers by Zongli Ding Breakdown of academic impact, for papers by Jianjun Xu Breakdown of academic impact, for papers by Jiaxiang Wang Breakdown of academic impact, for papers by Mehrdokht Sadrkhanloo Breakdown of academic impact, for papers by Jialin Feng Breakdown of academic impact, for papers by Elahe Sadat Hejazi
Rankless by CCL
2026